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Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging zoonotic disease, which causes high fever,
thrombocytopenia, and death in humans and animals in East Asian countries. The pathogenicity of SFTS virus (SFTS
V) remains unclear. We intraperitoneally infected three groups of mice: wild-type (WT), mice treated with blocking
anti-type I interferon (IFN)-α receptor antibody (IFNAR Ab), and IFNAR knockout (IFNAR−/−) mice, with four doses of
SFTSV (KH1, 5 × 105 to 5 × 102 FAID50). The WT mice survived all SFTSV infective doses. The IFNAR Ab mice died
within 7 days post-infection (dpi) with all doses of SFTSV except that the mice were infected with 5 × 102 FAID50
SFTSV. The IFNAR−/− mice died after infection with all doses of SFTSV within four dpi. No SFTSV infection caused
hyperthermia in any mice, whereas all the dead mice showed hypothermia and weight loss. In the WT mice, SFTSV
RNA was detected in the eyes, oral swabs, urine, and feces at 5 dpi. Similar patterns were observed in the IFNAR Ab
and IFNAR−/− mice after 3 dpi, but not in feces. The IFNAR Ab mice showed viral shedding until 7 dpi. The SFTSV
RNA loads were higher in organs of the IFNAR−/− mice compared to the other groups. Histopathologically,
coagulation necrosis and mononuclear inflammatory cell infiltration in the liver and white pulp atrophy in the
spleen were seen as the main lesions in the IFN signaling lacking mice. Immunohistochemically, SFTSV antigens
were mainly detected in the marginal zone of the white pulp of the spleen in all groups of mice, but more viral
antigens were observed in the spleen of the IFNAR−/− mice. Collectively, the IFN signaling-deficient mice were
highly susceptible to SFTSV and more viral burden could be demonstrated in various excreta and organs of the
mice when IFN signaling was inhibited.
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Introduction
Severe fever with thrombocytopenia syndrome (SFTS) is
an emerging viral zoonotic disease, caused by Dabie
Bandavirus [former SFTS virus (SFTSV)]. SFTSV is a
tick-borne virus belonging to the Genus Bandavirus
(former Huaiyangshan Banyangvirus), Family Phenuivir-
idae. SFTSV causes high fever, thrombocytopenia, and
leukocytopenia, followed by multi-organ dysfunction
(MOD) and death in humans in East Asian countries [1].
Since SFTSV was first identified in China in 2010, SFTS
cases have been identified in China, Japan, South Korea,
Vietnam, and Taiwan [2]. The fatality rate of SFTS is
high (6–32%) but more specific or effective treatments
or vaccines have not been developed yet [3]. Thus, SFTS
is listed in the World Health Organization Prioritized
Pathogens, which pose major public health risks and fur-
ther research and development are needed [4].
To study the pathogenesis of SFTSV and make thera-
peutics and vaccines, animal models with human-like
symptoms are essential. At present, rhesus macaque
monkeys, which had shown symptoms similar to
humans in other viral diseases, did not show human-like
symptoms when infected with SFTSV [5]. Old ferrets
and cats have been shown to exhibit human-like symp-
toms when infected with SFTSV, but many immune-
related functional studies cannot be performed in these
animals. Therefore, they have limitations as animal
models compared to mice [6, 7].
Interferons (IFNs) are key effectors of viral infection
in innate and adaptive immune systems and are cate-
gorized into three groups (type I, II, and III) [8].
Type I IFNs bind to a common IFN-α/β receptor
(IFNAR), which initiates a signaling cascade that in-
duces the expression of thousands of antiviral effector
function genes. Previous studies showed that type I
IFN response is essential for SFTSV infection [9–11].
Several studies have been conducted using mice as
animal models of SFTSV. The studies reported that
no clinical symptoms or deaths occurred in mice with
normal immune responses infected with SFTSV. Only
type I interferon (IFN)-deficient mouse models, new-
born mice, mitomycin-treated mice, and STAT2-
knockout (KO) hamsters are available as models for
the fatal illness caused by SFTSV infection [10, 12].
IFNAR KO (IFNAR−/−) mice have been previously
used as small animal models for SFTSV infection and
other emerging viruses, such as Zika virus (ZIKV)
and Rift valley fever virus [11, 13–15]. However,
IFNAR−/− mice models have particular use because
they lack a key component of antiviral immunity.
Thus, we utilized the IFNAR antibody (Mab, MAR1-
5A3) to inhibit the IFN signaling temporarily, which
allowed the mice with intact IFNAR, a key component
of antiviral immunity, to be infected with SFTSV.
Materials and methods
Viruses and cells
The Korean SFTSV strain KH1 (GenBank accession no.
MH491547, MH491548.1, MH491549.1) was kindly
provided by Dr. Joon-Seok Chae [16]. This virus was
passaged five times on monolayers of Vero E6 cells in
DMEM containing 5% fetal bovine serum (FBS) with an-
tibiotics (penicillin; 100 U/ml, streptomycin; 100 μg/ml).
The virus infectivity titers were determined through a
fluorescence active infectious dose (FAID50) assay.
Animal infection and sample collection
Six-week-old female C57BL/6 mice (WT, Samtako,
Kyoung Gi-do, Korea) and 6-week-old type 1 IFN recep-
tor knockout (IFNAR−/−) female mice were used in this
study. To study the correlation between immunologic
competence and the pathogenicity of SFTSV, MAR1-
5A3 (mouse anti-mouse IFNAR, IgG1) monoclonal anti-
body (MAb) was administered as an intraperitoneal (IP)
injection of 100 μg per mouse 1 day before SFTSV infec-
tion and 2 days post-infection (dpi) to the C57BL/6 mice
(IFNAR Ab mice). The IFNAR−/− mice, purchased from
B&K Universal (Hull, UK), were backcrossed onto
C57BL/6 mice for at least 10 generations. The Mice
were inoculated intraperitoneally (i.p.) with 5 × 105 to
5 × 102 FAID50 in a volume of 200 μL of phosphate-
buffered saline (PBS). Body temperature was obtained
using the rectal probes. Blood samples were collected
from the retro-orbital venous plexus and analyzed with
an automatic blood cell counter (Exigo-Vet., Boule Med-
ical AB Inc., Stockholm, Sweden). The sera were frozen
at − 80 °C until further analysis. Eye and oral swabs,
feces, and urine samples were placed in 200 μL of PBS
and stored at − 80 °C. The SFTSV infected mice were eu-
thanized and the organs were harvested aseptically. All
SFTSV infection studies were performed in an animal
biosafety level 3 laboratory. All animal experiments
followed the requirements of the Animal Care and Eth-
ics Committees of Jeonbuk National University (approval
number: JBNU 2019–002).
Detection of SFTSV RNA by reverse transcription-
polymerase chain reaction
Total RNA was isolated by using Hybrid-R™ (GeneAll,
Seoul, Korea). The RNA was reverse transcribed using a
ReverTra Ace qPCR RT Master Mix (TOYOBO, Osaka,
Japan) to generate cDNA. The viral copy numbers were
determined by real-time PCR (RT-PCR) with an L
segment-based SFTSV-specific primer. The forward
primer sequence was SFTSV-L-F: AACATCCTGG
ACCTTGCATC and the reverse primer sequence was
SFTSV-L-R: CAATGTGGCCATCTTCTCCA [17]. Copy
numbers were determined by comparison to a standard
control. RT-PCR was performed using CFX96 Real-time
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PCR (Bio-Rad Laboratories, Hercules, CA) with qPCR
SyGreen Mix (PCRbiosystems, Seoul, Korea).
Histopathology and immunohistochemistry
In the 5 × 102 FAID50 SFTSV infection experiment, four
mice from each group were necropsied 1, 3, 7, 12, and
17 dpi, and samples of the brain, lung, liver, spleen, kid-
ney, small intestine (s. intestine), and large intestine (l.
intestine) were obtained for histopathologic and immu-
nohistochemical examination and SFTSV genome quan-
tification by RT-PCR. The collected organ tissues were
fixed with 10% neutral phosphate-buffered formalin and
processed and embedded in paraffin according to stand-
ard procedures. The embedded tissues were sectioned to
6 μm thicknesses using a microtome (HM-340E; Thermo
Fisher Scientific Inc., Waltham, MA, USA) and placed
on slides. The sectioned tissues were stained with
hematoxylin and eosin (H&E) according to a standard
protocol. To detect the viral antigen by immunohisto-
chemistry, a mouse monoclonal antibody against SFTSV
N protein (kindly provided by Dr. Jun-Gu Choi, Animal
and Plant Quarantine Agency, Korea) was used as the
primary antibody.
Statistical analysis
Unless otherwise indicated, comparisons between the
groups in the in vivo experiments were performed by a
2-tailed Mann-Whitney test or one-way ANOVA
followed by Tukey’s multiple comparison test. A p-value
of < 0.05 was considered statistically significant.
Statistical analyses were performed by GraphPad Prism
version 8.00.
Results
Susceptibility to SFTSV in mice deficient in type I
interferon signaling
Three groups of mice were intraperitoneally infected
(WT, IFNAR Ab, and IFNAR−/− mice) with four
doses of SFTSV (KH1, 5 × 105 to 5 × 102 FAID50). The
WT mice showed no mortality from any dose of
SFTSV (Fig. 1a). In mice infected with 5 × 105, 5 ×
104, and 5 × 103 FAID50 SFTSV, the IFNAR Ab mice
showed 100% mortality 4, 5, and 7 dpi, respectively,
and showed steady weight loss until just before death.
However, in the 5 × 102 FAID50 SFTSV infection ex-
periment, the IFNAR Ab mice did not succumb to
SFTSV and recovered the lost weight after 7 dpi (Fig.
1b). This finding in the IFNAR Ab mice given a low
Fig. 1 Survival rate, weight loss, and body temperature of mice with different type I interferon signaling after SFTSV challenge. Three groups of
mice, C57 BL/6 (WT), mice treated with blocking anti-type I interferon-α receptor antibody (IFNAR Ab), and IFNAR knockout (IFNAR−/−) mice, were
intraperitoneally infected with four doses of SFTSV (KH1, 5 × 105 -5 × 102 FAID50). a Survival rates, b body weight (%), and body temperature (°C)
were analyzed
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dose SFTSV infection might be due to the half-life of
IFNAR Ab, which is 5.2 days. The antibody was
injected 1 day before infection and 2 dpi [18]. The
IFNAR−/− mice succumbed to SFTSV regardless of
the SFTSV dose (5 × 105 to 5 × 102 FAID50) within 4
dpi. No SFTSV-infected mice had hyperthermia (Fig.
1b), whereas all the dead mice showed temperature
reduction, ruffled fur, anorexia, depression, gastro-
intestinal symptoms, and loss of weight after virus in-
fection. To study the pathogenesis of SFTSV and the
potential role of IFNAR Ab mice as an animal model
for SFTSV, 20 mice of each group were inoculated
with 5 × 102 FAID50 SFTSV. The hematologic changes
were observed and viral burden determined.
Hematologic parameters
To evaluate the hematologic changes in the SFTSV-
infected mice, blood samples were collected by retro-
orbital plexus puncture every 2 days and complete blood
counts were performed. White blood cell (WBC) counts
in the WT mice remained within the reference range
(2600–10,100/μL), but the WBC count in the IFNAR Ab
mice increased slightly from 4 to 10 dpi and recovered
after 12 dpi (Fig. 2a). Severe thrombocytopenia was not
detected in any mice after SFTSV infection (Fig. 2b). A
decreasing pattern of RBCs and hematocrit levels was
observed in both groups until 12 dpi and the levels were
significantly lower in the IFNAR Ab mice compared to
the WT mice from 4 to 10 dpi (Fig. 2c, d).
Fig. 2 Blood cell count. Complete blood cell counts were conducted using an automated blood cell counter. The WBCs (a), platelets (b), RBCs (c),
and hematocrit (HCT) (d) were analyzed. The values shown are the mean + SD from five mice per group. * p < 0.05, **p < 0.01 relative to WT mice,
Mann-Whitney test
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SFTS viral load in various organs
To study the pathogenesis of SFTSV, four mice of each
5 × 102 SFTSV-infected group were necropsied 1, 3, 7,
12, and 17 dpi and the viral load for each organ were
evaluated. The SFTSV RNA in the tissues, including the
brain, lung, liver, spleen, kidney, s. intestine, and l. intes-
tine, was analyzed by RT-PCR. At 1 dpi, SFTSV RNA
was detected in all the tested organs, but there was no
significant difference in viral copy number among the
groups of mice (Fig. 3). However, 3 dpi, the IFNAR−/−
mice showed significantly higher (p < 0.05) SFTSV RNA
levels in all organs than those of the other two groups of
mice. The highest SFTSV RNA levels were detected in
the spleen compared to the other organs of the IFNA
R−/− mice. Similar SFTSV RNA viral levels were detected
in all organs of the WT and IFNAR Ab mice. SFTSV
RNA was not detected after 12 dpi in the brain and lung,
and after 17 dpi in the liver, kidney, s. intestine, and l.
intestine of the WT and IFNAR Ab mice. In the serum
samples, the IFNAR−/− mice showed significantly higher
SFTSV RNA than that of the IFNAR Ab mice 2 dpi.
SFTSV RNA was detected consistently until 14 dpi in
the WT and IFNAR Ab mice.
SFTS viral RNA detection in mice excreta
In mice infected with 5 × 102 FAID50 SFTSV, eye and
oral swabs, and urine and feces were collected 1, 3, 5, 7,
9, 11, 13, 15, and 17 dpi to evaluate viral antigen shed-
ding and the viral load for each sample were evaluated.
The WT mice showed no clinical symptoms at any day
post-infection with SFTSV. However, SFTS viral RNA
was detected in the eye and oral swabs, and urine and
feces 5 dpi (Fig. 6). In the case of the IFNAR Ab and
IFNAR−/− mice, SFTSV RNA was detected earlier than
that of the WT mice in the eye and oral swabs, and
urine (after 3 dpi), and the IFNAR Ab mice showed lon-
ger viral shedding than the WT mice (up to 7 dpi).
These results showed that the SFTSV-infected mice
could shed SFTS viral RNA, regardless of clinical symp-
toms, and SFTS viral RNA could be released for a longer
time in mice with downregulated IFN signaling.
Pathological examination
To assess the progression of SFTSV over time, histo-
pathology and IHC in each organ was examined in the
necropsy tissues of four mice inoculated i.p with 5 × 102
FAID50 SFTSV at 1, 3, 7, 12, and 17 dpi. The WT mice
had no observable histological abnormalities. Between
the two IFN signaling-regulated mice groups, lesions
were observed sooner in the IFNAR−/− mice. At 3 dpi,
coagulation necrosis in the liver and white pulp atrophy,
especially in the marginal zone of the spleen of the
IFNAR−/− mice, were observed (Figs. 4a and 5a). At 7
dpi, coagulation necrosis and mononuclear inflammatory
cell infiltration around the necrotic lesions of the liver
and white pulp atrophy in the spleen of the IFNAR Ab
mice were observed. Since one of the major clinical
manifestations of SFTS is gastrointestinal symptoms and
the SFTSV-infected IFNAR Ab and IFNAR−/− mice
showed gastrointestinal symptoms, we histopathologic-
ally evaluated the s. intestine and measured the villus/
crypt depth (V/C) ratio in the s. intestine. At least 20 V/
C ratios were measured for each mouse in the proximal
s. intestine. The WT mice had long, intact, regular villi
at all time points, and the V/C ratios did not differ sig-
nificantly (Fig. 4b, c). However, the IFNAR Ab and
IFNAR−/− mice showed shortening, damaged, blunting
villi, and the V/C ratios significantly decreased from 3
dpi. All IFNAR−/− mice succumbed to SFTSV at 3 dpi,
but the surviving IFNAR Ab mice recovered villus
morphology and V/C ratio from 12 dpi comparable to 1
dpi. In the present study, SFTS viral RNA was the most
enriched in the spleen of all SFTSV-infected mice and
previous studies suggested that the spleen may be the
primary target organ of SFTSV [10, 19]. Therefore, we
performed immunohistochemistry assays with spleen
sections isolated 3 dpi using a monoclonal antibody
against SFTSV N protein (NP). As shown in Fig. 5b, the
frequency of SFTSV NP antigen-positive cells was in the
order of IFNAR−/−, IFNAR Ab, and WT mice, consistent
with the qPCR results of this study. SFTSV NP antigen-
positive cells were rarely detected in the white pulp but
mainly detected in the marginal zone of the spleen, and
were monocyte-like cells in all groups of mice.
Discussion
In this study, we intraperitoneally inoculated different ti-
ters of SFTSV into WT, IFNAR Ab, and IFNAR−/− mice.
Similar to previous studies, the no immunocompetent
WT mice showed any clinical signs or died. However,
the IFNAR−/− mice succumbed to SFTSV within 3 dpi
even at small titers of SFTSV (5 × 102 FAID50). There-
fore, the IFNAR−/− mice might be not suitable to repre-
sent the clinical symptoms of human SFTSV infection.
The IFNAR Ab mice showed similar survival rates after
infection following inoculation with 5 × 105 to 5 × 103
FAID50. However, in mice infected with 5 × 10
2 FAID50
SFTSV, the IFNAR Ab mice survived and recovered
from 7 dpi (Fig. 1a). These findings showed that im-
munocompetent mice could be infected with SFTSV by
partially blocking type I IFN signaling. A previous study
tried to make a mouse model that did not cause clinical
symptoms in immunocompetent mice by injections of
type 1 IFNAR Ab to mice infected with ZIKV [14]. The
main symptom of ZIKV is related to central nervous sys-
tem effects. However, the type I IFNAR Ab did not pass
through the blood-brain barrier (BBB), so the main
symptoms of ZIKV infection were not recapitulated. But,
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in the present study, the IFNAR Ab mice recapitulated
the fatality of SFTSV infections because the main target
of SFTSV is a parenchymal organ, such as the spleen.
These findings suggest that transgenic mice can be used
for SFTS studies after the administration of IFNAR Ab,
allowing the study of various pathways involved in
SFTSV infections. At present, the strongest candidate
animal model of SFTSV infection might be aged ferrets
Fig. 3 SFTS viral qPCR results. Organs were harvested from WT and IFNAR Ab mice 1, 3, 7, 12, and 17 dpi with 5 × 102 FAID50 SFTSV by i.p.
infection. Organs from the IFNAR−/− mice were collected 1 and 3 dpi. Serum samples were collected 0, 2, 4, 6, 8, 10, 12, and 14 dpi. The solid
lines indicate the mean + SD from four mice per group. The SFTSV RNA loads were higher in the brain, lung, liver, spleen, small intestine, large
intestine, kidney, and serum of the mice. * p < 0.05, relative to IFNAR−/− mice, Mann-Whitney test
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because they exhibit symptoms similar to humans. How-
ever, because aged ferrets are outbred and generally un-
available for commercial use, this model has limitations
in studying the pathogenesis of SFTS [6].
In public health, the risk of infection from asymptom-
atic carriers has increased [20, 21]. Although human-to-
human or cat-to-human SFTSV transmissions have been
reported, the risk of infection from an asymptomatic
Fig. 4 Histopathological examinations and villus/crypt ratio from the SFTSV-infected mice. Mice were inoculated i.p. with 5 × 102 FAID50 SFTSV.
The liver and small intestine of the C57 BL6 wild-type (WT), mice treated with blocking anti-type I interferon (IFN)-α receptor antibody (IFNAR Ab)
were collected 1, 3, 7, and 12 dpi and the organs of the IFNAR knockout (IFNAR−/−) mice were collected 1 and 3 dpi after infection. a The
crosshatches and asterisks indicate coagulation necrosis and mononuclear cell infiltration in the liver, respectively. Bars 100 μm. b The WT mice
had long, intact, regular villi at all time points, but the IFNAR Ab and IFNAR−/− mice showed shortened, damaged, blunting villi, and the IFNAR
Ab mice recovered at 12 dpi. Bars 200 μm. c At least 20 typical villi and crypts were measured for each mouse. The villus/crypt ratios are
expressed as the mean ± standard deviation. Statistical analyses were performed using one-way ANOVA followed by Tukey’s multiple comparison
test. *p < 0.05 and **p < 0.01 for 1 dpi vs. other dpi for the same group mice. #p < 0.05 for 3dpi vs. 12 dpi for the IFNAR AB mice
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Fig. 5 Histopathological and immunohistochemical examinations of the spleen collected from the SFTSV-infected mice. Mice were inoculated i.p.
with 5 × 102 FAID50 SFTSV. Spleens of the WT and IFNAR Ab mice were collected 1, 3, 7, 12 dpi and the spleens of the IFNAR
−/− mice were
collected 1 and 3 dpi. a Asterisks indicate white pulp atrophy. Bars, 200 μm. H&E, hematoxylin and eosin staining. b The SFTSV N protein antigens
were confirmed in the spleens by immunohistochemistry (IHC). Bars, 100 μm
Fig. 6 Viral load detected in oral, eye swabs, urine and feces obtained from SFTSV-infected mice. Mice were inoculated i.p. with 5 × 102 FAID50
SFTSV. Samples of WT and IFNAR Ab mice were collected 1, 3, 5, 7 and 9 dpi and the samples of IFNAR KO mice were collected 1, 3 dpi. The
solid lines indicate the mean + SD from five mice per group
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animal carrier of SFTSV has not been confirmed [22,
23]. In this study, we confirmed that immunocompetent,
asymptomatic WT mice shed SFTS viral RNA 5 dpi
through various excreta (Fig. 6). As expected, the IFNAR
Ab mice, which showed clinical signs, shed SFTS viral
RNA from 3 to 7 dpi. Since our system could only detect
and measure SFTSV RNA, the infectious titers of SFTSV
need to be determined in a future study. Furthermore,
studies on whether asymptomatic carrier mice can infect
other mice are needed.
A previous study suggested that SFTSV targeted mac-
rophages, immature B cells, and reticular cells in the
IFNAR−/− mice [10]. The IHC results showed that
SFTSV antigens were mainly detected in monocyte-like
cells in the marginal zone of the white pulp of spleen,
regardless of the group of mice (Fig. 5b). Marked mar-
ginal zone reduction in the spleen was the main differ-
ence between the dead IFNAR−/− and the surviving mice
(Fig. 5a). The marginal zone has a key role in the anti-
viral response and especially, marginal zone metallophi-
lic macrophages (MOMA) are important for initiating
an antiviral B cell response [24]. Furthermore, deficiency
in humoral responses and the disruption of B cell im-
munity affected fatal human SFTSV infection [25]. Based
on these results, it is speculated that reductions in the
marginal zone and MOMA might affect humoral re-
sponse deficiency in the SFTSV-infected mice without
IFN signaling. Therefore, it will be necessary to deter-
mine the mechanism of how IFN signaling deficiency af-
fects humoral immunity after SFTSV infection.
Our findings showed that healthy asymptomatic mice
could shed SFTSV via various excreta and the IFNAR
Ab mice had some limitations in hematologic manifest-
ation but recapitulated the fatality of SFTSV infections.
Conclusions
Regulation of type I IFN signaling by injecting type 1
IFNAR Ab into different types of immunocompromised
mice will help to elucidate the pathogenesis of SFTSV
infection with small quantities of virus.
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